Study identification

EU PAS number

EUPAS35558

Study ID

38213

Official title and acronym

REACT-SCOT Pharmacoepidemiology (REACT-SCOT-PHARM)

DARWIN EU® study

No

Study countries

United Kingdom

Study description

Observational analysis of the association of COVID-19 with drug exposures: A case control study in the population of Scotland

Study status

Ongoing
Research institutions and networks

Institutions

University of Edinburgh (UofE)
United Kingdom
First published:
16/12/2024
Institution Educational Institution Hospital/Clinic/Other health care facility ENCePP partner
Public Health Scotland Glasgow, Scotland

Contact details

Helen Colhoun

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:
Actual:

Date of interim report, if expected

Planned:

Date of final study report

Planned:
Sources of funding
Other

More details on funding

Public Health Scotland
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable